2. HISTORY
Zenker, a pathologist,1st identified fat
embolism syndrome at autopsy 1862.
First diagnosed in 1873 by Dr Von
Bergmann
1879 Fenger and Salisbury published
description of FES
UMY
3. Some definitions…
Fat Emboli: Fat particles or droplets
that travel through the circulation
Fat Embolism: A process by which fat
emboli passes into the bloodstream
and lodges within a blood vessel.
Fat Embolism Syndrome (FES):
serious manifestation of fat embolism
occasionally causes multi system
dysfunction, the lungs are always
involved and next is brain
UMY
4. Causes of FES
Blunt
Trauma
(90%)
Long bone
(Femur,
tibia, pelvic)
factures
UMY
5. Causes of FES(cntd.)
More frequent in CLOSED # than OPEN #
Younger pts > old patients d/t increased bone
marrow.
A single bone # has 1-5% chances of developing FES,
directly correlates with the no. of long bone fractures.
FES has been reported as high as 33% in b/l shaft
femur fractures.
UMY
6. Causes of FES
• Non Trauma: agglutination of chylomicrons and VLDL
by high levels of plasma CRP.
– disease-related
• Diabetes, acute pancreatitis, burns, SLE, sickle cell crisis
– drug-related
• parenteral lipid infusion
– procedure-related
• Orthopedic surgery, liposuction
UMY
7. Pathophysiology of FES
Exact mechanism unknown, but two main hypothesis
• Mechanical vs. Biochemical
• Mechanical – Fat globules from disrupted bone
marrow or adipose tissue are forced into torn venules
in areas of trauma.
• Biochemical – Hormonal changes caused by trauma
and/or sepsis induce systemic release of free fatty
acids (FFA) as chylomicrons which cause the systemic
FES.
UMY
8. Mechanical hypothesis-
– Fractures of marrow-containing bone (Femur,
Pelvis) have the highest incidence of FES and
cause the largest volume of fat emboli, because the
disrupted venules in the marrow remain tethered
open by their osseous attachments.
– The marrow contents enter the venous circulation
with little difficulty.
UMY
9. Mechanical hypothesis (cntd.)
This theory is supported by research on Orthopaedic
long bone (IM reaming) and spinal surgeries which
cause fat globules to enter the blood circulation when
vigorous reaming/fixation is done.
Increased Pressure + Volume Extravasation
Measuring fat globules pre and post reaming shows
significant difference in concentration.
UMY
10. Cntd.-
Fat droplets are deposited in the pulmonary capillary
beds and travel through arteriovenous shunts to the
brain. Systems affected include LUNG, BRAIN and
CIRCULATION.
Microvascular lodging of droplets produces local
ischemia and inflammation, with concomitant release
of inflammatory mediators, platelet aggregation, and
vasoactive amines.
UMY
11. Biochemical Hypothesis-
FES is dependent upon degradation of the embolized
fat into free fatty acids.
Neutral fat does not cause an acute lung injury, it is
hydrolyzed over the course of hours to several
products, including FFA, which cause ARDS in animal
models.
CRP (acute phase reactant), which is elevated in
trauma patients, appears to be responsible in lipid
agglutination (FES) for both traumatic and non-
traumatic FES.
UMY
12. Biochemical theroy (cntd.)
The process of Neutral fat cells -> FFA ->
Agglutination with CRP may explain the time
sequence of clinical findings in FES.
Onset of symptoms may coincide with Agglutination.
This theory is animal model based and circumstantial
at best.
UMY
13. CLINICAL PRESENTATION-
Diagnosis is made clinically NOT chemically. It does
not matter how much fat globules are in your
circulation, it just matters if you have their side
effects.
FES typically manifests 24 to 72 hours after the initial
insult. Rarely <12 hrs or >72 hrs.
Classic triad: Hypoxemia; Neurologic abnormalities;
and a Petechial Rash
UMY
15. Pulmonary
Hypoxia, rales, pleural friction rub
ARDS may develop
½ of pts with FES require mechanical ventilation
(Bulger, Archives of Surgery 1997; 132: 435-9)
CXR usually normal early on, later may show
‘snowstorm’ pattern- diffuse bilateral infiltrates
CT chest: ground glass opacification with interlobular
septal thickening
UMY
17. Neurological findings
Usually occur after respiratory symptoms.
Incidence 80% patients with FES
Minor global dysfunction most common, but
ranges from mild delirium to coma.
Seizures/focal deficits not common but can occur
Transient and reversible in most cases
CT Head: general edema, usu nonspecific
MRI brain: Low density on T1, and high intensity
T2 signal, correlates to degree of impairment
UMY
18. MRI showing foci of ischemia
suggestive of fat embolism
syndrome
post operative day 14 and
shows evolving cortical
infarctions
post operative day 2
showing multiple
hyperintense areas
consistent with multiple
emboli
Source:http://www.ispub.com/journal/the_internet_journal_of_anesthesiology/volume_19_number_2/article/acute_fatal_fat_embolism_syndrome_in_bilateral_total_knee_arthroplasty_a_review_of_the_fat_embolism_syndrome.html
UMY
19. Rash
Petechial
Usually on conjuntiva,neck, axillae
Results from occlusion of dermal capillaries by fat
globules and then extravasations of RBC
Resolves in 5-7 days
Pathognomonic, but only present in 20-50% of
patients
UMY
23. DIAGNOSIS-
FES is CLINICAL diagnosis, not biochemical.
A high degree of suspicion is needed to make diagnosis .
-Common misconception that the presence of fat globules, either
in sputum, urine, or a wedged PA catheter, is necessary to
confirm the diagnosis of FES
In 50% of fracture patients, fat globules was demonstrated in
the serum, without symptoms of FES.
HOWEVER
Growing literature on the use of bronchoscopy with
bronchoalveolar lavage to detect fat droplets in alveolar
macrophages as a means to diagnose fat embolism. Sensitivity
and specificity are unknown, being studied in Trauma patients. .
UMY
24. Gurd’s Criteria
FES = 1 major + 4 minor + fat microglobulinemia
Still widely used today
Major features Minor features
Petechial rash Tachycardia> 120 /min
Respiratory symptoms
plus bilateral signs with
positive radiographic
changes
Pyrexia > 39.4 ℃
Retinal fat or petechiae
Urinary fat globules or oligoanuria
Sudden drop in Hb level > 20%
Cerebral signs
unrelated to head injury
Sudden thrombocytopenia > 50%
High ESR > 71 mm/h
UMY
25. Lindeque’s Criteria
FES = femur fracture ± tibia fracture + 1 feature
Based on respiratory parameters
A sustained PaO2 < 8 kPa (60 mmHg)
A sustained PaCO2 > 7.3 kPa (55 mmHg) or pH <
7.3
A sustained respiratory rate > 35 /min even after
adequate sedation
Increased work of breathing judged by dyspnea,
use of accessory muscles, tachycardia and anxiety
UMY
28. SUB CLINICAL FES
Around 3 days post trauma
Probably occurs in almost all long bone
fractures of the lower extremity and fractures of the
pelvis
Characterised by decreased PaO2, decreased Hb% and
decreased platelets. No clinical signs and symptoms of
respiratory insufficiency.
UMY
29. NON FULMINANT FES
- Any time ,upto 6 days post trauma
-Clinical signs and symptoms are clearly
evident.
Petechiae, tachycardia, respiratory failure, and signs of
CNS embolism.
Thrombocytopaenia, anaemia, and coagulation
abnormalities can be found, as can pulmonary alveolar
and interstitial opacities on chest x ray
UMY
30. There is no definitive test for this version of the
syndrome, as most of the changes described can occur
as a result of trauma as well as a result of fat
embolism, the diagnosis remains a clinical one, and
the significance is uncertain.
UMY
31. FULMINANT FES
Occurs very suddenly and rapidly after injury, and
progresses very quickly, often resulting in death
within a few hours of the initial trauma.
Clinical features are acute respiratory failure, acute
cor pulmonale and embolic neurological changes.
These occur shortly after injury and often result in the
death of the patient.
UMY
32. Pats. with multiple fractures are particularly
susceptible to this form of the syndrome, which,
although it is relatively rare, is of immense clinical
significance because of its high mortality.
UMY
33. TREATMENT-
ATLS protocol
1. Early immobilization of fracture and early
definitive reduction (open or closed).
2. Maintain intravascular volume to maintain
cardiovascular stability (hypovolemic shock
resuscitation), may use colloids (albumin) as it can
expand fluid and bind FFA.
3. Mechanical ventilation with PEEP
UMY
34. Rx (cntd.)
4. IV Ethanol has been used in Russia, Europe and some
American centres to decrease rate of FES.
J Bone Joint Surg Am. 1977 Oct;59(7):878-80
“A raised level of alcohol in the blood was associated with a
lower incidence of fat embolism” all other variables controlled.
- Other studies
- Can J Surg. 1970 Jan;13(1):41-9
- Br Med J. 1978 May 13;1(6122):1232-4
UMY
35. Rx- STEROIDS
Steroid prophylaxis is controversial to prevent FES
Theorized blunting of inflammatory response and
complement activation
Prospective studies suggests prophylactic steroids
benefit high risk patients
Few studies and small study size, so remains
controversial.
Once FES established, steroids have not shown
improved outcomes.
UMY
36. Rx-HEPARIN
Like steroids, controversial role in management.
Stimulates lipase to reduce lipemia.
Reverses the DIC picture.
S/E- Inc in circulating free fatty acids,
-bleeding risks
Routine use not recommended.
UMY
37. Rx-SUMMARY
Treatment
The overall outcomes of FES with respect to isolated long
bone, pelvis and spine fractures is good with standard
immobilization and reduction of fracture, fluid
resuscitation and ventilator y support as needed.
Steroids and Ethanol treatments can be adjuncts to
treatment, but most be started early.
Recommended to start with low dose and for a
period of 24-48 hours.
No evidence on Steroids or Ethanol Tx once FES is
diagnosed. This is only for Prophylaxis
UMY